COVID-19 and heart failure: from epidemiology during the pandemic to myocardial injury, myocarditis, and heart failure sequelae

L Italia, D Tomasoni, S Bisegna, E Pancaldi… - Frontiers in …, 2021 - frontiersin.org
A close and intriguing relationship has been suggested between heart failure (HF) and
coronavirus disease 2019 (COVID-19). First, COVID-19 pandemic represented a global …

Emerging biomarkers for the detection of cardiovascular diseases

S Thupakula, SSR Nimmala, H Ravula… - The Egyptian Heart …, 2022 - Springer
Background The prevalence of cardiovascular disease (CVD) has been continuously
increasing, and this trend is projected to continue. CVD is rapidly becoming a significant …

Combined role of troponin and natriuretic peptides measurements in patients with Covid-19 (from the Cardio-COVID-Italy multicenter study)

A Iorio, CM Lombardi, C Specchia, M Merlo… - The American Journal of …, 2022 - Elsevier
Data concerning the combined prognostic role of natriuretic peptide (NP) and troponin in
patients with COVID-19 are lacking. The aim of the study is to evaluate the combined …

B-type natriuretic peptide concentrations, COVID-19 severity, and mortality: a systematic review and meta-analysis with meta-regression

A Zinellu, S Sotgia, C Carru… - Frontiers in Cardiovascular …, 2021 - frontiersin.org
Alterations in cardiac biomarkers have been reported in patients with coronavirus disease
2019 (COVID-19) in relation to disease severity and mortality. We conducted a systematic …

[HTML][HTML] Subclinical myocardial injury, coagulopathy, and inflammation in COVID-19: A meta-analysis of 41,013 hospitalized patients

O Ogungbe, B Kumbe, OA Fadodun, T Latha… - IJC Heart & …, 2022 - Elsevier
Background Infection with the SARS-CoV-2 virus can lead to myocardial injury, evidenced
by increases in specific biomarkers and imaging. Objective To quantify the association …

Myocardial injury predicts risk of short-term all-cause mortality in patients with COVID-19: A dose–response meta-analysis

Y Li, H Pei, C Zhou, Y Lou - Frontiers in Cardiovascular Medicine, 2022 - frontiersin.org
Objective Predictive value of myocardial injury as defined by elevated cardiac tropnins
(cTns) in patients with COVID-19 has not been fully investigated. We performed a meta …

[HTML][HTML] Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2

A Muthyala, S Sasidharan, KJ John, A Lal… - World Journal of …, 2022 - ncbi.nlm.nih.gov
BACKGROUND Cardiovascular complications have been increasingly recognized in the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) associated coronavirus …

Cardiac troponin as a predictor of myocardial injury and mortality from COVID-19

JHP Nascimento, BFO Gomes… - Arquivos Brasileiros de …, 2020 - SciELO Brasil
In Brazil, until August 1, 2020, 2,707,877 cases of COVID-19 were diagnosed, with 93,563
deaths. the lethality rate for the country, in this period, was 3.5% with mortality variable …

Covid-19 and Heart Involvement: A Systematic Review of Literature

FCA Moraes, RRE Santos, JC Moraes… - International Journal of …, 2023 - SciELO Brasil
Background Recent reports in the literature have indicated that infection by coronavirus
disease 2019 (COVID-19) causes cardiac complications, such as heart failure, arrhythmia …

[HTML][HTML] Cardiac biomarkers in patients with COVID-19: pragmatic tools in hard times

F Cannata, S Bombace, GG Stefanini - Revista Espanola de …, 2021 - ncbi.nlm.nih.gov
Almost 1 year has passed since the first cases of interstitial pneumonia due to severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) were reported in Wuhan, China. 1 …